• Log In
  • Account Access
  • Contact Us

    Pre-Sales Support

    Mutual Funds and ETFs - 800-456-7526
    Monday-Thursday: 8:00 a.m. – 6:00 p.m. ET
    Friday: 8:00 a.m. – 5:00 p.m. ET

    ETF Trading Support - 415-315-6600
    Monday-Friday: 9:30 a.m. – 5:00 p.m. ET

    Post-Sales and Website Support
    Monday-Friday: 9:00 a.m. - 6:00 p.m. ET

Hartford Healthcare Fund

Explore Another ETFs


Seeks long-term capital appreciation.


A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

More About Healthcare Fund 

The Health-Care Revolution

The health-care sector is undergoing dramatic changes that will impact everything from the drugs we take to the way patients’ medical records are shared. Aging demographics globally and rising prosperity in emerging-market nations will drive even greater demand for lifesaving drugs, innovative procedures, and disruptive medical technology.

Pipeline to Innovation

With innovation and breakthroughs taking place across the globe, the Fund uses a broadly diversified, global approach that seeks to identify companies with the greatest opportunities in areas including biotechnology, medical technology, health services, and pharmaceuticals.

Backed by Size, Scale, and Experience

Wellington Management, the Fund’s sub-adviser, is one of the largest managers of health care stocks in the world. The portfolio managers on the Fund average 26 years of experience.

Jean M. Hynes, CFA
Senior Managing Director
Global Industry Analyst
Ann C. Gallo
Senior Managing Director
Global Industry Analyst
Robert L. Deresiewicz
Senior Managing Director
Global Industry Analyst

Portfolio managers are supported by the full resources of Wellington Management.


Performance (%)
% (as of 2/28/2018)
Average Annual Total Returns % (as of 2/28/2018)
Hartford Healthcare  I 2.73 11.69 6.45 17.72 12.83 11.86
Benchmark 2.22 15.08 7.53 16.50 12.45 ---
Morningstar Health Category 3.23 15.68 4.62 16.66 12.96 ---
Performance (%)
% (as of 12/31/2017)
Average Annual Total Returns % (as of 12/31/2017)
Hartford Healthcare  I 21.94 21.94 8.09 19.15 11.70 11.81
Benchmark 22.47 22.47 8.82 17.98 11.36 ---
Morningstar Health Category 24.34 24.34 6.30 17.92 11.75 ---
SI = Since Inception. Fund Inception: 05/01/2000
Operating Expenses:   Net  1.03% |  Gross  1.03%

Share Class Inception: 8/31/06.
Class I-share performance prior to its inception date reflects Class A-share performance (excluding sales charges) and operating expenses. SI performance is calculated from 5/1/00.

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Prior to 4/1/2016, the Fund's benchmark was the S&P North American Health Care Sector Index.

Growth of $10,000

(as of 2/28/2018)

Growth of $10,000

Reflects Class A, excluding sales charges. If sales charges and taxes had been included, the value would have been lower. Results for other classes will vary.


I-Share Morningstar Ratings
(as of 2/28/2018)
  • Overall
  • Overall Morningstar Rating for Healthcare Fund, Class I, as of 2/28/2018 out of 128 products in the Health Category Based on Risk-Adjusted Returns

Morningstar Analyst Rating


Morningstar awarded the Fund a Bronze analyst rating on 11/10/171

Calendar Year Returns (%)
Fund Benchmark
2017 21.94 22.47
2016 -8.33 -2.05
2015 12.97 7.41
2014 26.80 24.79
2013 49.95 42.19
2012 20.14 18.35
2011 8.03 11.88
2010 6.69 5.20
2009 21.74 20.76
2008 -25.27 -23.76

Excludes sales charges. If sales charges and taxes had been included, the value would have been lower.

Characteristics Holdings are subject to change. Percentages may be rounded.

As of Date 2/28/2018
Net Assets $1.4 billion
# of Holdings 108
Beta 1.16
R Squared 0.93
% in Equities 99%
Turnover (12/31/2017) 18%
% in Foreign Equities 13%
Standard Deviation 15.92%
Holdings Characteristics
(as of 2/28/2018)
Fund S&P Composite 1500 Health Care Index
Asset Weighted Market Cap $51.4 billion $119.2 billion
EPS Growth Rate 20.5% 11.0%
Median Market Cap $5.0 billion $3.8 billion
Price/Book 3.5x 4.0x
Price/Earnings 30.8x 15.8x
Return on Equity 1.6% 23.1%
Return Characteristics
(as of 2/28/2018)
Alpha -0.83
Down Capture 113.73
Information Ratio 0.27
Sharpe Ratio 1.21
Up Capture 113.39
Market Cap Distribution %
(as of 02/28/2018)
Less than $2 billion 13.0
$2 billion - $5 billion 12.3
$5 billion - $10 billion 7.2
Greater than $10 billion 67.5

Top Ten Holdings (%)

(as of 2/28/2018)
label percentageholding
UnitedHealth Group, Inc. 6.15
Bristol-Myers Squibb Co. 4.55
Medtronic plc 4.37
Allergan plc 2.98
Boston Scientific Corp. 2.93
Stryker Corp. 2.82
Thermo Fisher Scientific, Inc. 2.67
Eli Lilly & Co. 2.47
Alkermes plc 2.29
AstraZeneca plc 2.29
Total Portfolio % 33.52
(as of 12/31/2017)
label percentageholding
UnitedHealth Group, Inc. 6.39
Medtronic plc 4.71
Bristol-Myers Squibb Co. 4.31
Allergan plc 3.37
Celgene Corp. 3.13
Eli Lilly & Co. 2.89
Stryker Corp. 2.87
Boston Scientific Corp. 2.84
Thermo Fisher Scientific, Inc. 2.60
AstraZeneca plc 2.55
Total Portfolio % 35.66
Fund Essentials
Inception Date 05/01/2000
Symbol HGHIX
CUSIP 416649887
Fund Number 1309

Subsector Exposure

(as of 2/28/2018)
label currentpercentage
Biopharma Mid Cap 19%
Biopharma Small Cap 11%
Health Care Services 24%
Medical Technology 27%
Biopharma Large Cap 20%
(as of 12/31/2017)
label currentpercentage
Biopharma Mid Cap 16%
Biopharma Small Cap 9%
Health Care Services 24%
Medical Technology 26%
Biopharma Large Cap 25%

Based on sub-adviser’s classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap.  Excludes cash. May not total to 100% due to rounding.



Client Conversations: HSAs: 1 Account, 3 Tax Benefits 

Thu Feb 15 12:00:00 EST 2018
Have a health savings account, but not contributing to it? You could be missing out.

The 5-Minute Forecast 

Thu Jan 11 10:44:00 EST 2018
A concise summary of the Hartford Funds Multi-Asset Team’s views on the main challenges facing investors: Growth, Income, Volatility, Inflation, and Taxes.

2018 Outlooks (Schroders) 

Fri Dec 22 14:06:00 EST 2017
Thought leaders from Schroder Investment Management provide their outlook on issues that may influence markets and portfolios going forward.


Fund Literature

Select All

Fact Sheet

12/31/2017 | pdf
Get FINRA Letter

Max 100


12/31/2017 | pdf
Get FINRA Letter

Max 100

Expanded Commentary

12/31/2017 | pdf

Max 100

Summary Prospectus

03/01/2018 | pdf

Available For
Download Only


12/31/2017 | pdf

Available For
Download Only

Semi Annual Report

04/30/2017 | pdf

Available For
Download Only

Statutory Prospectus

03/01/2018 | pdf

Available For
Download Only

Annual Report

10/31/2017 | pdf

Available For
Download Only

Fund Story

12/31/2017 | pdf
Get FINRA Letter

Max 100


03/01/2017 | pdf

Available For
Download Only

Financial Professionals:

Log in to order forms and literature and manage your subscriptions.


Investing involves risk, including the possible loss of principal. There is no guarantee a fund will achieve its stated objective. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. Risks of focusing investments on the healthcare related sector include regulatory and legal developments, patent considerations, intense competitive pressures, rapid technological changes, potential product obsolescence, and liquidity risk. Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political and economic developments. These risks may be greater for investments in emerging markets. Small- and mid-cap securities can have greater risks and volatility than large-cap securities.

1 The Morningstar Analyst Rating is not a credit or risk rating. It is a subjective evaluation performed by the manager research analysts of Morningstar. Morningstar evaluates funds based on five key pillars, which are process, performance, people, parent, and price. Analysts use this five pillar evaluation to determine how they believe funds are likely to perform over the long term on a risk-adjusted basis. They consider quantitative and qualitative factors in their research, and the weighting of each pillar may vary. The Analyst Rating scale is Gold, Silver, Bronze, Neutral, Negative. A Morningstar Analyst Rating of Gold, Silver, or Bronze reflects an Analyst’s conviction in a fund’s prospects for outperformance. Analyst Ratings are continuously monitored and reevaluated at least every 14 months. The Morningstar Analyst Rating should not be used as the sole basis in evaluating a mutual fund. Morningstar Analyst Ratings involve unknown risks and uncertainties which may cause Morningstar’s expectations not to occur or to differ significantly from what we expected. For more detailed information about Morningstar’s Analyst rating, including its methodology, please go to

© 2018 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/ or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.